SEAGEN

seagen-logo

SEAGEN focuses on intelligent warehousing and distribution, and intelligent manufacturing system solutions.

#People #Financial #Website #More

SEAGEN

Industry:
Information Technology Manufacturing Warehousing

Founded:
2007-01-01

Address:
Nanshanqu, Guangdong, China

Country:
China

Website Url:
http://www.seagen.cn

Total Employee:
101+

Status:
Active

Contact:
86 755 21679797

Email Addresses:
sales@seagen.cn

Total Funding:
110 M CNY

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Domain Not Resolving Mobile Non Scaleable Content IIS DigiCert SSL IIS 8 Encryption Everywhere


Current Employees Featured

vaughn-himes_image

Vaughn Himes
Vaughn Himes Chief Technical Officer @ SEAGEN
Chief Technical Officer

clay-siegall_image

Clay Siegall
Clay Siegall President, Chief Executive Officer & Co-Founder @ SEAGEN
President, Chief Executive Officer & Co-Founder

todd-e-simpson_image

Todd E. Simpson
Todd E. Simpson CFO @ SEAGEN
CFO

Founder


clay-siegall_image

Clay Siegall

Stock Details


Company's stock symbol is NEEQ:835742

Investors List

nanjing-gaoke_image

Nanjing Gaoke

Nanjing Gaoke investment in Post-IPO Equity - SEAGEN

china-venture-capital-hrvc-jiangsu-huarui-investment-management-co_image

China Venture Capital HRVC

China Venture Capital HRVC investment in Post-IPO Equity - SEAGEN

Official Site Inspections

http://www.seagen.cn

  • Host name: 47.115.52.87
  • IP address: 47.115.52.87
  • Location: Hangzhou China
  • Latitude: 30.294
  • Longitude: 120.1619
  • Timezone: Asia/Shanghai

Loading ...

More informations about "SEAGEN"

Seagen - Pfizer

With Seagen’s proprietary, world-leading Antibody-Drug Conjugate (ADC) technology, together with the scale and strength of Pfizer's capabilities and expertise, we are poised to change the …See details»

Seagen - Wikipedia

Seagen Inc. (formerly Seattle Genetics, Inc.) is an American biotechnology company focused on developing and commercializing innovative, empowered monoclonal antibody-based therapies for the treatment of cancer. The company, headquartered in Bothell, Washington (a suburb of Seattle), is the industry leader in antibody-drug conjugates or ADCs, a technology designed to harness the tar…See details»

SEAGEN - Crunchbase Company Profile & Funding

Contact Email sales@seagen.cn; Phone Number 86 755 21679797; SEAGEN offers digital twin solutions, smart park solutions, intelligent sorting solutions, and warehousing solutions. Their …See details»

Seagen - 百度百科

2021年8月,国内上市生物医药公司荣昌生物公告称,已与美国知名生物医药公司西雅图基因(Seagen)达成合作,将其自主研发的抗体偶联药物(ADC)维迪西妥单抗在除大中华区及 …See details»

Advancing Oncology Innovation: Celebrating One Year of Pfizer

Dec 20, 2024 Pfizer has a longstanding commitment to advancing innovative cancer treatments to help improve outcomes for patients worldwide. One year ago, Pfizer’s acquisition of Seagen …See details»

深圳市欣视景科技股份有限公司 - SEAGEN

深圳市欣视景科技股份有限公司成立于2007年,位于深圳市高新技术产业园区,马鞍山国资委占有11%股份,是一家专注于智能制造场内供应链智能化数字化领域整体解决方案的集研发、销售、设计、制造和服务于一体的高新技术企业。See details»

SEAGEN

通过物联网、大数据和工业智能引擎打通企业设备和系统间的数据脉络,深入挖掘数据价值,并在孪生技术支持下打造高保真、实时同步的虚拟实体,构建1:1复刻现实的工业元宇宙。See details»

三优药讯|一文了解被辉瑞430亿美元收购的 Seagen

北京时间2023年3月13日, 辉瑞 (Pfizer)宣布将以每股229美元现金收购Seagen,总企业价值约430亿美元。 相对于Seagen目前322亿美元的市值,此次辉瑞可谓大幅溢价33%完成了收购,比去年默沙东(MSD)与Seagen传出 …See details»

美国生物技术公司:西雅图遗传学公司 Seagen …

May 23, 2015 西雅图遗传学公司 Seagen Inc.(SGEN)美股百科. Seagen Inc.(前身为 Seattle Genetics, Inc.)是一家美国 生物技术公司 ,专注于开发和商业化创新的、强化的单克隆抗体癌症治疗疗法。 该公司总部位于华盛顿州博塞尔( …See details»

Pfizer Completes Acquisition of Seagen

Dec 14, 2023 Pfizer completed its acquisition of all outstanding common stock of Seagen for $229 in cash per share, for a total enterprise value of approximately $43 billion. “Cancer …See details»

(sgen)股票公司摘要_美股_新浪财经_新浪网 - sina

Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the …See details»

Seagen Company Profile - Office Locations, Competitors ... - Craft

Seagen (formerly known as Seattle Genetics) is a biotechnology company that develops and commercializes targeted therapies to treat cancer. Its products include ADCETRIS, for the …See details»

RemeGen signs global licensing agreement on anti-cancer drug

Yantai-based biotech innovator RemeGen signed an exclusive worldwide licensing agreement with the internationally well-known biopharmaceutical company Seagen Inc on Aug 8 to …See details»

Seagen-Seagen, Inc.-企业详情-InvestGO数据库-ByDrug-医药魔方 …

Dec 31, 1997 查看医药魔方InvestGO®数据库Seagen的公司信息。Seagen(Seagen, Inc.),公司简介:Seattle Genetics is a clinical-stage biotechnology company, focuses on developing …See details»

Pfizer Receives All Required Regulatory Approvals to Complete the ...

Dec 12, 2023 Expects to close Seagen acquisition on December 14, 2023 Announces changes in the commercial organization to incorporate Seagen and improve focus, speed and …See details»

深圳市欣视景股份有限公司 - seagen.cn

通过物联网、大数据和工业智能引擎打通企业设备和系统间的数据脉络,深入挖掘数据价值,并在孪生技术支持下打造高保真、实时同步的虚拟实体,构建1:1复刻现实的工业元宇宙。See details»

In $2.6B cancer deal, Seagen bets China's first homemade ADC can ...

Aug 9, 2021 For $200 million upfront, Seagen is getting ex-Asia rights to RemeGen’s HER2-targeted disitamab vedotin. The drug is a direct threat to Roche’s Kadcyla and AstraZeneca …See details»

RemeGen signs global licensing agreement on anti-cancer drug

RemeGen will gain potential revenue of up to $2.6 billion from the transaction. Seagen will acquire a global development and commercialization right, while RemeGen will retain the rights to …See details»

Pfizer's (formerly Seagen) integrated supply chain: From clinical ...

Oct 24, 2023 Supply chains play a critical role in any organization, but for biopharma company Pfizer (formerly Seagen), robust supply and demand planning processes could mean the …See details»

Pfizer Invests $43 Billion to Battle Cancer

Mar 13, 2023 Pfizer to acquire Seagen for $229 per Seagen share in cash, for a total enterprise value of approximately $43 billion Proposed combination enhances Pfizer’s position as a …See details»

linkstock.net © 2022. All rights reserved